Kymera Therapeutics KYMR Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $144.09M+60.2% | $357.01M+197% | $112.95M+2.0% | $335.82M+397% | $89.97M-3.8% | ||
| $506.84M+35.8% | $491.27M+33.3% | $392.73M-10.6% | $329.63M-25.5% | $373.18M-12.6% | ||
| $677.43M+35.2% | $871.21M+70.7% | $528.3M-7.1% | $728.33M+38.6% | $500.95M-6.8% | ||
| $41.62M-15.4% | $43.18M-14.4% | $45.13M-11.9% | $48.57M-6.1% | $49.17M-0.3% | ||
| $1.67B+81.7% | $1.74B+78.2% | $1.1B+6.5% | $1.13B+36.9% | $918.31M+5.8% | ||
| $12.84M+25.1% | $4.02M-33.0% | $5.51M-15.2% | $5.78M-11.2% | $10.26M+50.7% | ||
| $0-100% | $22.93M+68.9% | $23.28M+16.3% | $40M+108% | $11.48M-49.3% | ||
| $1.7M+9.1% | $1.82M+19.6% | $1.89M+40.7% | $1.9M+91.5% | $1.56M+37.6% | ||
| $62.64M+6.2% | $83.21M+22.8% | $71.58M+7.6% | $87.54M+40.9% | $58.99M+5.1% | ||
| $129.38M-2.0% | $163.15M+14.6% | $155.79M+9.8% | $159.59M+13.1% | $132.08M-15.9% | ||
| $8K+14.3% | $8K+14.3% | $7K0.0% | $7K+16.7% | $7K+16.7% | ||
| -$1.14B-38.4% | -$1.07B-41.3% | -$978.98M-43.2% | -$896.81M-44.3% | -$820.19M-41.6% | ||
| $1.54B+95.8% | $1.58B+89.0% | $946.26M+6.0% | $971.48M+41.8% | $786.23M+10.5% | ||
| $1.67B+81.7% | $1.74B+78.2% | $1.1B+6.5% | $1.13B+36.9% | $918.31M+5.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kymera Therapeutics's total assets?
- Kymera Therapeutics (KYMR) holds $1.7B in total assets, up 81.8% year over year.
- How much debt does Kymera Therapeutics have?
- Kymera Therapeutics carries $82.2M in total debt against $1.5B of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does Kymera Therapeutics have?
- Kymera Therapeutics holds $144.1M in cash and equivalents.
- Can Kymera Therapeutics cover its short-term obligations?
- Its current ratio is 10.81 — current assets exceed current liabilities.
- Where does Kymera Therapeutics's balance sheet data come from?
- Every line is extracted from Kymera Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
